Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HepQuant, LLC logo — Transforming Liver Health

HepQuant, LLC

Transforming Liver Health

Founded 2007 United States Denver, United States 24 employees Biotechnology, Health Care +1

General Information

Company Name HepQuant, LLC
Founded Year 2007
Location United States Denver, United States
Employees 24
Industries Biotechnology, Health Care, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with HepQuant, LLC. To contact HepQuant, LLC, visit hepquant.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About HepQuant, LLC

is a biotechnology company founded in 2007 and based in the United States. Their slogan, "Leading the way with innovative technology for assessing liver function in chronic liver disease patients," reflects their mission to revolutionize liver health assessment. The company specializes in developing non-invasive, quantitative tests that measure liver health. One of their key products, the HepQuant DuO Test, provides comprehensive information about liver cell function and portal-systemic shunting, which are crucial attributes associated with clinical outcomes in liver disease. This test offers healthcare providers valuable insights, enabling them to more effectively manage patients with liver diseases. Its results can be used by physicians in conjunction with clinical evaluation and other tests to aid in decision-making processes related to invasive procedures, treatment monitoring, and predicting disease progression and adverse outcomes. This application of advanced technology contributes to more personalized and informed patient care in the field of liver disease treatment. As of now, specific details about last investment and investors are not available. However, the innovative approach and the potential impact of HepQuant's technology in the biotechnology, healthcare, and life sciences sectors make it an entity to watch for modernizing diagnostic and treatment practices in chronic liver diseases.

Taxonomy: medical diagnostics, liver function, chronic liver disease, non-invasive tests, quantitative tests, portal-systemic shunting, liver health assessment, treatment monitoring, disease progression, clinical outcomes, innovative medical testing, healthcare management, pharmaceutical solutions

No funding data available for HepQuant, LLC yet.

HepQuant, LLC Alternatives & Competitors

HepQuant, LLC vs
ENDRA Life Sciences (Nasdaq: NDRA)
ENDRA Life Sciences (Nasdaq: NDRA) United States

Focused on early detection of liver disease

Post-IPO Equity
25 employees
Biotechnology, Health Care
HepQuant, LLC vs
Aspira Women's Health
Aspira Women's Health United States

Globally transforming women's health, starting with ovarian cancer.

Post-IPO Equity
66 employees
Biotechnology, Health Care
HepQuant, LLC vs
SuperSonic Imagine
SuperSonic Imagine France

Innovations in Ultrasound.

Post-IPO Equity
165 employees
Biotechnology, Health Care

FAQ About HepQuant, LLC

Transforming Liver Health
HepQuant, LLC was founded in 2007.
HepQuant, LLC is headquartered in Denver, United States.
HepQuant, LLC operates in Biotechnology, Health Care and Life Sciences. Its work centres on medical diagnostics, liver function, chronic liver disease and non-invasive tests.
HepQuant, LLC has approximately 24 employees.
Top alternatives and competitors to HepQuant, LLC include ENDRA Life Sciences (Nasdaq: NDRA), Aspira Women's Health, SuperSonic Imagine, Nanomed Diagnostic Biotechnology, Fractyl Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HepQuant, LLC and ENDRA Life Sciences (Nasdaq: NDRA) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HepQuant, LLC, https://bouncewatch.com/company/hepquant-llc, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes